Bessemer Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $687M | Buy |
3,157,936
+42,695
| +1% | +$9.47M | 1.08% | 13 |
|
|
2025
Q4 | $712M | Buy |
3,115,241
+361,273
| +13% | +$82.3M | 1.09% | 11 |
|
|
2025
Q3 | $638M | Sell |
2,753,968
-11,440
| -0.4% | -$2.33M | 0.98% | 15 |
|
|
2025
Q2 | $513M | Buy |
2,765,408
+12,455
| +0.5% | +$2.31M | 0.83% | 19 |
|
|
2025
Q1 | $577M | Buy |
2,752,953
+1,641,091
| +148% | +$319M | 1.03% | 18 |
|
|
2024
Q4 | $198M | Sell |
1,111,862
-173,905
| -14% | -$32M | 0.32% | 73 |
|
|
2024
Q3 | $254M | Buy |
1,285,767
+5,629
| +0.4% | +$1.05M | 0.42% | 54 |
|
|
2024
Q2 | $220M | Sell |
1,280,138
-48,319
| -4% | -$8M | 0.39% | 63 |
|
|
2024
Q1 | $242M | Sell |
1,328,457
-52,182
| -4% | -$8.99M | 0.44% | 54 |
|
|
2023
Q4 | $214M | Buy |
1,380,639
+11,770
| +0.9% | +$1.72M | 0.42% | 55 |
|
|
2023
Q3 | $204M | Sell |
1,368,869
-504,140
| -27% | -$74M | 0.45% | 56 |
|
|
2023
Q2 | $252M | Sell |
1,873,009
-1,319
| -0.1% | -$193K | 0.54% | 47 |
|
|
2023
Q1 | $299M | Buy |
1,874,328
+15,413
| +0.8% | +$2.36M | 0.71% | 30 |
|
|
2022
Q4 | $300M | Buy |
1,858,915
+23,476
| +1% | +$3.6M | 0.73% | 34 |
|
|
2022
Q3 | $246M | Sell |
1,835,439
-201,939
| -10% | -$29M | 0.64% | 36 |
|
|
2022
Q2 | $312M | Buy |
2,037,378
+31,389
| +2% | +$4.8M | 0.78% | 27 |
|
|
2022
Q1 | $325M | Buy |
2,005,989
+22,384
| +1% | +$3.25M | 0.68% | 33 |
|
|
2021
Q4 | $269M | Buy |
1,983,605
+210,403
| +12% | +$24.9M | 0.54% | 44 |
|
|
2021
Q3 | $191M | Buy |
1,773,202
+14,759
| +0.8% | +$1.69M | 0.41% | 71 |
|
|
2021
Q2 | $198M | Buy |
1,758,443
+227,939
| +15% | +$25.7M | 0.43% | 63 |
|
|
2021
Q1 | $166M | Buy |
1,530,504
+104,687
| +7% | +$11.2M | 0.4% | 72 |
|
|
2020
Q4 | $153M | Buy |
1,425,817
+9,763
| +0.7% | +$938K | 0.4% | 75 |
|
|
2020
Q3 | $124M | Buy |
1,416,054
+151,599
| +12% | +$14.3M | 0.37% | 83 |
|
|
2020
Q2 | $124M | Buy |
1,264,455
+47,104
| +4% | +$4.15M | 0.39% | 72 |
|
|
2020
Q1 | $92.8M | Buy |
1,217,351
+277,451
| +30% | +$23.6M | 0.37% | 76 |
|
|
2019
Q4 | $83.2M | Sell |
939,900
-32,868
| -3% | -$2.73M | 0.27% | 104 |
|
|
2019
Q3 | $73.7M | Sell |
972,768
-1,548
| -0.2% | -$106K | 0.26% | 113 |
|
|
2019
Q2 | $70.9M | Buy |
974,316
+249
| +0% | +$19.6K | 0.24% | 123 |
|
|
2019
Q1 | $78.5M | Buy |
974,067
+26,424
| +3% | +$2.16M | 0.3% | 106 |
|
|
2018
Q4 | $87.4M | Buy |
947,643
+918,170
| +3,115% | +$80.7M | 0.38% | 85 |
|
|
2018
Q3 | $2.79M | Buy |
29,473
+439
| +2% | +$41.6K | 0.01% | 323 |
|
|
2018
Q2 | $2.69M | Sell |
29,034
-2,832
| -9% | -$277K | 0.01% | 336 |
|
|
2018
Q1 | $3.02M | Sell |
31,866
-504
| -2% | -$55.4K | 0.01% | 338 |
|
|
2017
Q4 | $3.13M | Sell |
32,370
-4,911
| -13% | -$463K | 0.01% | 340 |
|
|
2017
Q3 | $3.31M | Buy |
37,281
+2,291
| +7% | +$174K | 0.01% | 338 |
|
|
2017
Q2 | $2.54M | Sell |
34,990
-4,116
| -11% | -$277K | 0.01% | 401 |
|
|
2017
Q1 | $2.55M | Sell |
39,106
-6,381
| -14% | -$401K | 0.01% | 430 |
|
|
2016
Q4 | $2.85M | Sell |
45,487
-12,496
| -22% | -$763K | 0.01% | 409 |
|
|
2016
Q3 | $3.66M | Sell |
57,983
-10,180
| -15% | -$659K | 0.02% | 338 |
|
|
2016
Q2 | $4.22M | Sell |
68,163
-15,867
| -19% | -$967K | 0.02% | 323 |
|
|
2016
Q1 | $4.8M | Buy |
84,030
+26,034
| +45% | +$1.45M | 0.03% | 303 |
|
|
2015
Q4 | $3.44M | Buy |
57,996
+5,406
| +10% | +$311K | 0.02% | 319 |
|
|
2015
Q3 | $2.86M | Sell |
52,590
-13,311
| -20% | -$866K | 0.02% | 353 |
|
|
2015
Q2 | $4.43M | Sell |
65,901
-1,434
| -2% | -$93.6K | 0.02% | 294 |
|
|
2015
Q1 | $3.94M | Sell |
67,335
-610
| -0.9% | -$36.9K | 0.02% | 286 |
|
|
2014
Q4 | $4.45M | Buy |
67,945
+19,476
| +40% | +$1.23M | 0.02% | 273 |
|
|
2014
Q3 | $2.8M | Sell |
48,469
-2,222
| -4% | -$123K | 0.02% | 319 |
|
|
2014
Q2 | $2.86M | Buy |
50,691
+1,788
| +4% | +$93.8K | 0.02% | 293 |
|
|
2014
Q1 | $2.51M | Sell |
48,903
-22,946
| -32% | -$1.16M | 0.02% | 292 |
|
|
2013
Q4 | $3.79M | Buy |
71,849
+21,445
| +43% | +$1.05M | 0.03% | 247 |
|
|
2013
Q3 | $2.26M | Sell |
50,404
-10,215
| -17% | -$453K | 0.02% | 281 |
|
|
2013
Q2 | $2.5M | Buy |
+60,619
| New | +$2.65M | 0.02% | 261 |
|
Other funds holding ABBV
VCM
VPM
Bessemer Group's ABBV Position: Q1 2026 in Review
Bessemer Group increased its AbbVie (ABBV) stake by 1.4% in Q1 2026, buying an estimated $9.47M and bringing the position to 3,157,936 shares worth $687M. The position accounts for 1.08% of the portfolio, ranked #13.
Bessemer Group first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $712M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Bessemer Group held 3,157,936 shares of AbbVie worth $687M as of Q1 2026.
- Bessemer Group bought 42,695 AbbVie shares in Q1 2026, an estimated $9.47M.
- AbbVie made up 1.08% of Bessemer Group's portfolio in Q1 2026, its #13 holding.
- Bessemer Group first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Bessemer Group's AbbVie position peaked at $712M in Q4 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.